Microba Life Sciences Limited (ASX:MAP) Insider Purchases A$34,200.00 in Stock

Microba Life Sciences Limited (ASX:MAP) insider Pasquale (Paddy) Rombola bought 200,000 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The shares were acquired at an average price of A$0.17 ($0.11) per share, for a total transaction of A$34,200.00 ($22,207.79).

Microba Life Sciences Price Performance

The company has a debt-to-equity ratio of 3.84, a quick ratio of 6.50 and a current ratio of 2.61.

About Microba Life Sciences

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, and Singapore. The company operates through two segments, Testing Services, and Research and Development.